Skin problems in lower limb amputees: an overview by case reports.

PubWeight™: 1.00‹?› | Rank: Top 15%

🔗 View Article (PMID 17243947)

Published in J Eur Acad Dermatol Venereol on February 01, 2007

Authors

H E J Meulenbelt1, J H B Geertzen, P U Dijkstra, M F Jonkman

Author Affiliations

1: Centre for Rehabilitation, University Medical Centre Groningen, University of Groningen, The Netherlands. h.e.j.meulenbelt@rev.umcg.nl

Articles by these authors

Revised classification system for inherited epidermolysis bullosa: Report of the Second International Consensus Meeting on diagnosis and classification of epidermolysis bullosa. J Am Acad Dermatol (2000) 1.97

Phantom pain and phantom sensations in upper limb amputees: an epidemiological study. Pain (2000) 1.81

Skin sensitivity to UVB irradiation in systemic lupus erythematosus is not related to the level of apoptosis induction in keratinocytes. Rheumatology (Oxford) (2005) 1.59

The ultrastructure of acantholysis in pemphigus vulgaris. Br J Dermatol (2008) 1.58

Quantitative analysis of traction in the glenohumeral joint. In vivo radiographic measurements. Man Ther (2003) 1.55

Management of bullous pemphigoid: the European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology. Br J Dermatol (2015) 1.55

Persistent failures in gene repair. Nat Biotechnol (2001) 1.54

Late morbidity after treatment of breast cancer in relation to daily activities and quality of life: a systematic review. Eur J Surg Oncol (2003) 1.41

Dexamethasone pulse therapy in pemphigus. J Eur Acad Dermatol Venereol (2002) 1.40

Prosthetic prescription in the Netherlands: an interview with clinical experts. Prosthet Orthot Int (2004) 1.38

Deficiency of the integrin beta 4 subunit in junctional epidermolysis bullosa with pyloric atresia: consequences for hemidesmosome formation and adhesion properties. J Cell Sci (1996) 1.37

Treatment-related upper limb morbidity 1 year after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast cancer. Ann Surg Oncol (2004) 1.31

A mutation in human keratin K6b produces a phenocopy of the K17 disorder pachyonychia congenita type 2. Hum Mol Genet (1998) 1.28

Keratin 17 mutations cause either steatocystoma multiplex or pachyonychia congenita type 2. Br J Dermatol (1998) 1.28

Long term treatment related upper limb morbidity and quality of life after sentinel lymph node biopsy for stage I or II breast cancer. Eur J Surg Oncol (2006) 1.21

Filaggrin mutations in the onset of eczema, sensitization, asthma, hay fever and the interaction with cat exposure. Allergy (2009) 1.18

Test-retest reliability of the Isernhagen Work Systems Functional Capacity Evaluation in patients with chronic low back pain. J Occup Rehabil (2003) 1.15

Mutations in KRT5 and KRT14 cause epidermolysis bullosa simplex in 75% of the patients. Br J Dermatol (2011) 1.08

Adhesive stripping to remove epidermis in junctional epidermolysis bullosa for revertant cell therapy. Br J Dermatol (2009) 1.06

Therapeutic outcome assessment in permanent temporomandibular joint disc displacement. J Oral Rehabil (1999) 1.06

Abnormal landing strategies after ACL reconstruction. Scand J Med Sci Sports (2009) 1.06

Test-retest reliability of the Isernhagen Work Systems Functional Capacity Evaluation in healthy adults. J Occup Rehabil (2004) 1.04

Relationship between psychological factors and performance-based and self-reported disability in chronic low back pain. Eur Spine J (2008) 1.03

Variation in repeated mouth-opening measurements in head and neck cancer patients with and without trismus. Int J Oral Maxillofac Surg (2008) 1.03

Reliability and stability of the Roland Morris Disability Questionnaire: intra class correlation and limits of agreement. Disabil Rehabil (2004) 1.02

IgG-induced clustering of desmogleins 1 and 3 in skin of patients with pemphigus fits with the desmoglein nonassembly depletion hypothesis. Br J Dermatol (2011) 1.02

Exercise adherence in patients with trismus due to head and neck oncology: a qualitative study into the use of the Therabite. Int J Oral Maxillofac Surg (2009) 1.00

Comparing self-report, clinical examination and functional testing in the assessment of work-related limitations in patients with chronic low back pain. Disabil Rehabil (2005) 1.00

Measuring somatic symptoms with the CES-D to assess depression in cancer patients after treatment: comparison among patients with oral/oropharyngeal, gynecological, colorectal, and breast cancer. Psychosomatics (2006) 0.97

Smallest detectable difference in outcome variables related to painful restriction of the temporomandibular joint. J Dent Res (1999) 0.96

Gait analysis in prosthetics: opinions, ideas and conclusions. Prosthet Orthot Int (2002) 0.95

Acquired palmoplantar keratoderma and immunobullous disease associated with antibodies to desmocollin 3. Br J Dermatol (2007) 0.94

Satisfaction with treatment outcome in bilateral cleft lip and palate patients. Int J Oral Maxillofac Surg (2007) 0.94

Shoulder complaints after nerve sparing neck dissections. Int J Oral Maxillofac Surg (2004) 0.93

Shoulder and neck morbidity in quality of life after surgery for head and neck cancer. Head Neck (2004) 0.93

Bullous pemphigoid and linear IgA dermatosis sera recognize a similar 120-kDa keratinocyte collagenous glycoprotein with antigenic cross-reactivity to BP180. J Invest Dermatol (1997) 0.93

Long term effect (more than five years) of intrathecal baclofen on impairment, disability, and quality of life in patients with severe spasticity of spinal origin. J Neurol Neurosurg Psychiatry (2004) 0.93

Short-term outcome of arthroscopic surgery of temporomandibular joint osteoarthrosis and internal derangement: a randomized controlled clinical trial. Br J Oral Maxillofac Surg (1993) 0.92

Long-term follow-up of patients with Herlitz-type junctional epidermolysis bullosa. Br J Dermatol (2012) 0.92

Literature review of the possible advantages of silicon liner socket use in trans-tibial prostheses. Prosthet Orthot Int (2005) 0.92

Test-retest reliability of lifting and carrying in a 2-day functional capacity evaluation. J Occup Rehabil (2002) 0.91

Short and long term mortality rates after a lower limb amputation. Eur J Vasc Endovasc Surg (2013) 0.91

Low-dose rituximab is effective in pemphigus. Br J Dermatol (2012) 0.91

Epidemiology of ankle and foot overuse injuries in sports: A systematic review. Scand J Med Sci Sports (2012) 0.89

Linear IgA bullous dermatosis in a patient with renal cell carcinoma. Br J Dermatol (2001) 0.89

Work status and chronic low back pain: exploring the International Classification of Functioning, Disability and Health. Disabil Rehabil (2006) 0.89

Influence of efforts of employer and employee on return-to-work process and outcomes. J Occup Rehabil (2011) 0.89

Survival of flexible, braided, bonded stainless steel lingual retainers: a historic cohort study. Eur J Orthod (2008) 0.89

Effect of flat insoles with different Shore A values on posture stability in diabetic neuropathy. Prosthet Orthot Int (2007) 0.89

Shoulder complaints after neck dissection; is the spinal accessory nerve involved? Br J Oral Maxillofac Surg (2003) 0.88

Relationship between impairments, disability and handicap in reflex sympathetic dystrophy patients: a long-term follow-up study. Clin Rehabil (1998) 0.88

Reinforced poly(L-lactic acid) fibres as suture material. J Appl Biomater (1995) 0.88

Randomized controlled trial on physical therapy for TMJ closed lock. J Dent Res (2012) 0.88

Lethal acantholytic epidermolysis bullosa due to a novel homozygous deletion in DSP: expanding the phenotype and implications for desmoplakin function in skin and heart. Br J Dermatol (2010) 0.87

Laboratory diagnosis of paraneoplastic pemphigus. Br J Dermatol (2013) 0.87

Successful treatment of recalcitrant penicillamine-induced pemphigus foliaceus by low-dose intravenous immunoglobulins. Br J Dermatol (1999) 0.87

Systemic therapy with immunosuppressive agents and retinoids in hidradenitis suppurativa: a systematic review. Br J Dermatol (2013) 0.87

Herlitz junctional epidermolysis bullosa: diagnostic features, mutational profile, incidence and population carrier frequency in the Netherlands. Br J Dermatol (2011) 0.86

Pharmacokinetics of high-dose oral and intravenous dexamethasone. Ther Drug Monit (1999) 0.86

Validity and intra- and interobserver reliability of an indirect volume measurements in patients with upper extremity lymphedema. Lymphology (2004) 0.85

Stressful life events and psychological dysfunction in Complex Regional Pain Syndrome type I. Clin J Pain (1998) 0.85

[Spontaneous blood blister formation swellings of the oral mucosa]. Ned Tijdschr Tandheelkd (2003) 0.85

Construct validity of instruments measuring impairments in body structures and function in rheumatic disorders: which constructs are selected for validation? A systematic review. Clin Exp Rheumatol (2006) 0.85

Oral mucositis and selective elimination of oral flora in head and neck cancer patients receiving radiotherapy: a double-blind randomised clinical trial. Br J Cancer (2003) 0.85

Type XVII collagen (BP180) and LAD-1 are present as separate trimeric complexes. J Invest Dermatol (1999) 0.85

Cicatricial pemphigoid with circulating autoantibodies to beta4 integrin, bullous pemphigoid 180 and bullous pemphigoid 230. Br J Dermatol (2001) 0.84

Bullous eosinophilic cellulitis (Wells' syndrome) associated with Churg-Strauss syndrome. J Eur Acad Dermatol Venereol (2003) 0.84

Material handling performance of patients with chronic low back pain during functional capacity evaluation: a comparison between three countries. Disabil Rehabil (2006) 0.84

Junctional epidermolysis bullosa of late onset explained by mutations in COL17A1. Br J Dermatol (2011) 0.84

LAD-1 is absent in a subset of junctional epidermolysis bullosa patients. J Invest Dermatol (1997) 0.83

Localized and generalized forms of blistering in junctional epidermolysis bullosa due to COL17A1 mutations in the Netherlands. Br J Dermatol (2007) 0.83

Successful dexamethasone pulse therapy in a toxic epidermal necrolysis (TEN) patient featuring recurrent TEN to oxazepam. Clin Exp Dermatol (2001) 0.83

Bullous pemphigoid and epidermolysis bullosa acquisita. Differentiation by fluorescence overlay antigen mapping. Arch Dermatol (1996) 0.83

Reasons for drop-out in rehabilitation treatment of native patients and non-native patients with chronic low back pain in the Netherlands: a medical file study. Eur J Phys Rehabil Med (2010) 0.83

Barriers and facilitators of sports in Dutch Paralympic athletes: An explorative study. Scand J Med Sci Sports (2013) 0.83

Complaints related to mandibular function impairment after closed treatment of fractures of the mandibular condyle. Int J Oral Maxillofac Surg (2010) 0.83

The many faces of epidermolysis bullosa acquisita after serration pattern analysis by direct immunofluorescence microscopy. Br J Dermatol (2011) 0.83

Reliability and safety of functional capacity evaluation in patients with whiplash associated disorders. J Occup Rehabil (2013) 0.83

LAMB3 mutations in generalized atrophic benign epidermolysis bullosa: consequences at the mRNA and protein levels. Lab Invest (1998) 0.83

Sexuality in people with a lower limb amputation: a topic too hot to handle? Disabil Rehabil (2013) 0.82

A new porous polyetherurethane wound covering. J Biomed Mater Res (1990) 0.82

U-serrated immunodeposition pattern differentiates type VII collagen targeting bullous diseases from other subepidermal bullous autoimmune diseases. Br J Dermatol (2004) 0.82

Autoantibodies in anti-p200 pemphigoid stain skin lacking laminin 5 and type VII collagen. Br J Dermatol (2000) 0.82

A novel mutation in the L12 domain of keratin 1 is associated with mild epidermolytic ichthyosis. Br J Dermatol (2010) 0.82

Therapy of pemphigus. Clin Dermatol (2001) 0.82

Ultrastructure of acantholysis in pemphigus foliaceus re-examined from the current perspective. Br J Dermatol (2012) 0.81

Muscle strength in patients with chronic pain. Clin Rehabil (2003) 0.81